Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2022-05-13 |
2022-03 |
0 |
N/A |
N/A |
N/A |
2022-03-17 |
2021-12 |
-2.45 |
N/A |
N/A |
N/A |
2021-11-10 |
2021-09 |
-2.45 |
N/A |
N/A |
N/A |
2021-08-10 |
2021-06 |
-2.45 |
N/A |
N/A |
N/A |
2021-05-12 |
2021-03 |
-2.45 |
N/A |
N/A |
N/A |
2021-03-11 |
2020-12 |
-2.45 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2022-02-23 |
BTIG |
Downgrade |
Buy |
Neutral |
2021-03-15 |
Maxim Group |
Upgrade |
|
Buy |
2020-11-25 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2020-10-02 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2020-04-09 |
H.C. Wainwright |
Upgrade |
|
Buy |
2020-03-27 |
BTIG |
Upgrade |
|
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2021-06-09 |
ELMS STEVEN A |
Director |
2.74M |
Stock Award(Grant) |
2021-06-09 |
GRAIS LINDA S |
Director |
22.50K |
Stock Award(Grant) |
2021-11-22 |
GREATHOUSE KENNETH R |
Director |
43.50K |
Sale |
2021-06-09 |
HAGAN JOSEPH PATRICK |
Director |
22.50K |
Stock Award(Grant) |
2022-03-30 |
KELLERMAN DONALD J |
Officer |
56.33K |
Sale |
2021-06-03 |
LEWIS HAYLEY |
Officer |
49.78K |
Sale |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2022-03-30 |
Geode Capital Management, LLC |
900.32K |
7.09M |
18.37% |
2022-03-30 |
Vanguard Group, Inc. (The) |
147.11K |
1.16M |
3.00% |
2022-03-30 |
Aisling Capital Management LP |
77.66K |
611.59K |
1.58% |
2022-03-30 |
Blackrock Inc. |
58.60K |
461.49K |
1.20% |
2022-03-30 |
State Street Corporation |
12.47K |
98.18K |
0.25% |
2022-03-30 |
Renaissance Technologies, LLC |
7.12K |
56.03K |
0.15% |
Report Date |
Organization |
Position |
Value |
Percentage |
2022-03-30 |
Vanguard Total Stock Market Index Fund |
90.04K |
709.08K |
1.84% |
2022-03-30 |
Vanguard Extended Market Index Fund |
47.96K |
377.72K |
0.98% |
2022-03-30 |
Fidelity Extended Market Index Fund |
15.80K |
124.44K |
0.32% |
2022-03-30 |
Vanguard Institutional Index-Inst Total Stock Market Ind |
4.09K |
32.23K |
0.08% |
2022-03-30 |
Vanguard Balanced Index Fund |
3.75K |
29.49K |
0.08% |
2022-03-30 |
Fidelity Total Market Index Fund |
3.74K |
29.41K |
0.08% |
Split |
Date |
1 : 35 |
2022-04-12 |
1 : 20 |
2018-01-26 |